Fulgent Genetics, Inc.
FLGT
$18.50
$0.191.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -81.01% | -41.69% | 73.94% | 68.78% | 75.43% |
| Total Depreciation and Amortization | 0.08% | -3.23% | -4.22% | -6.53% | -6.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.61% | 13.69% | -69.46% | -65.48% | -71.77% |
| Change in Net Operating Assets | -315.19% | -1,525.00% | -125.34% | -4,290.59% | -274.92% |
| Cash from Operations | -1,062.41% | -582.61% | -86.12% | -168.33% | -77.80% |
| Capital Expenditure | 43.73% | 44.01% | 46.09% | -39.27% | -69.12% |
| Sale of Property, Plant, and Equipment | -80.70% | -98.40% | -99.23% | -93.67% | -93.17% |
| Cash Acquisitions | -- | -- | 1,046.12% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 194.73% | 809.35% | 175.75% | 233.14% | 189.46% |
| Cash from Investing | 471.04% | 290.86% | 1,197.96% | 1,303.11% | 521.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 44.05% | 50.96% | 74.59% | 81.55% | 92.84% |
| Issuance of Common Stock | -80.39% | -98.04% | -- | -- | 1,600.00% |
| Repurchase of Common Stock | -304.24% | -345.58% | 48.94% | 52.68% | 59.13% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -266.71% | -205.12% | 52.14% | 57.23% | 73.30% |
| Foreign Exchange rate Adjustments | 288.00% | 290.91% | -146.43% | 177.55% | 110.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -444.47% | 88.27% | 330.12% | 238.67% | 210.82% |